LENZ Therapeutics announces the commercial launch of its VIZZ product line, alongside a market share comparison in refill rates.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.